Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Tiede

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Xenotransplantation|January 1, 2010
Pigs transgenic for human thrombomodulin have elevated production of activated protein CBjörn Petersen, Wolf Ramackers, Andreas Tiede, et al.
Thrombosis and Haemostasis|December 31, 2019
Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia AAndreas Tiede, Ana Rosa Cid, Georg Goldmann, et al.
Blood|May 17, 2017
Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia AJoerg Kahle, Aleksander Orlowski, Diana Stichel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2019
Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statementAndreas Tiede, Paul Giangrande, Jerome Teitel, et al.
Xenotransplantation|March 13, 2008
Effects of pharmacological intervention on coagulopathy and organ function in xenoperfused kidneysWolf Ramackers, Lars Friedrich, Andreas Tiede, et al.
Annals of Hematology|October 14, 2014
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)Stephan Kreher, Sebastian Ochsenreither, Ralf U Trappe, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
[Use of Thrombopoetin-Receptor-Agonists (TPO-RA) in patients with liver cirrhosis before invasive procedures]Marcus M Mücke, Tony Bruns, Ali Canbay, et al.
Leukemia|March 8, 2025
Anti-CD19 CAR-T cell therapy for acquired hemophilia AChristian R Schultze-Florey, Felicitas R Thol, Krasimira Aleksandrova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 29, 2019
SHP656, a polysialylated recombinant factor VIII (PSA-rFVIII): First-in-human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia AAndreas Tiede, Geoffrey Allen, Alexander Bauer, et al.
Blood|July 29, 2021
Prothrombotic immune thrombocytopenia after COVID-19 vaccinationAndreas Tiede, Ulrich J Sachs, Andreas Czwalinna, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Xenotransplantation|January 1, 2010
Pigs transgenic for human thrombomodulin have elevated production of activated protein CBjörn Petersen, Wolf Ramackers, Andreas Tiede, et al.
Thrombosis and Haemostasis|December 31, 2019
Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia AAndreas Tiede, Ana Rosa Cid, Georg Goldmann, et al.
Blood|May 17, 2017
Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia AJoerg Kahle, Aleksander Orlowski, Diana Stichel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2019
Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statementAndreas Tiede, Paul Giangrande, Jerome Teitel, et al.
Xenotransplantation|March 13, 2008
Effects of pharmacological intervention on coagulopathy and organ function in xenoperfused kidneysWolf Ramackers, Lars Friedrich, Andreas Tiede, et al.
Annals of Hematology|October 14, 2014
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)Stephan Kreher, Sebastian Ochsenreither, Ralf U Trappe, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
[Use of Thrombopoetin-Receptor-Agonists (TPO-RA) in patients with liver cirrhosis before invasive procedures]Marcus M Mücke, Tony Bruns, Ali Canbay, et al.
Leukemia|March 8, 2025
Anti-CD19 CAR-T cell therapy for acquired hemophilia AChristian R Schultze-Florey, Felicitas R Thol, Krasimira Aleksandrova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 29, 2019
SHP656, a polysialylated recombinant factor VIII (PSA-rFVIII): First-in-human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia AAndreas Tiede, Geoffrey Allen, Alexander Bauer, et al.
Blood|July 29, 2021
Prothrombotic immune thrombocytopenia after COVID-19 vaccinationAndreas Tiede, Ulrich J Sachs, Andreas Czwalinna, et al.
Pageof 13